162 related articles for article (PubMed ID: 17922224)
1. A novel synthetic oleanolic acid derivative (CPU-II2) attenuates liver fibrosis in mice through regulating the function of hepatic stellate cells.
Wu LM; Wu XX; Sun Y; Kong XW; Zhang YH; Xu Q
J Biomed Sci; 2008 Mar; 15(2):251-9. PubMed ID: 17922224
[TBL] [Abstract][Full Text] [Related]
2. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
4. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production.
Hisamori S; Tabata C; Kadokawa Y; Okoshi K; Tabata R; Mori A; Nagayama S; Watanabe G; Kubo H; Sakai Y
Liver Int; 2008 Nov; 28(9):1217-25. PubMed ID: 18397230
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.
Wang X; Wang Q; Burczynski FJ; Kong W; Gong Y
Phytomedicine; 2013 Nov; 20(14):1330-5. PubMed ID: 23969230
[TBL] [Abstract][Full Text] [Related]
8. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver.
Chen YW; Liu BW; Zhang YJ; Chen YW; Dong GF; Ding XD; Xu LM; Pat B; Fan JG; Li DG
J Hepatol; 2010 Sep; 53(3):528-36. PubMed ID: 20646773
[TBL] [Abstract][Full Text] [Related]
9. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
10. JNK1 and JNK2 regulate α-SMA in hepatic stellate cells during CCl4 -induced fibrosis in the rat liver.
Hong IH; Park SJ; Goo MJ; Lee HR; Park JK; Ki MR; Kim SH; Lee EM; Kim AY; Jeong KS
Pathol Int; 2013 Oct; 63(10):483-91. PubMed ID: 24134609
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.
Chen M; Liu J; Yang W; Ling W
Autophagy; 2017; 13(11):1813-1827. PubMed ID: 29160747
[TBL] [Abstract][Full Text] [Related]
12. Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.
Ji L; Xue R; Tang W; Wu W; Hu T; Liu X; Peng X; Gu J; Chen S; Zhang S
FEBS Lett; 2014 Jun; 588(12):2095-100. PubMed ID: 24815695
[TBL] [Abstract][Full Text] [Related]
13. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
14. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
[TBL] [Abstract][Full Text] [Related]
15. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
Wang JJ; Li J; Shi L; Lv XW; Cheng WM; Chen YY
J Pharm Pharmacol; 2010 Jul; 62(7):935-42. PubMed ID: 20636883
[TBL] [Abstract][Full Text] [Related]
16. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.
Roderfeld M; Weiskirchen R; Wagner S; Berres ML; Henkel C; Grötzinger J; Gressner AM; Matern S; Roeb E
FASEB J; 2006 Mar; 20(3):444-54. PubMed ID: 16507762
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
19. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
20. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
